| Date Filed | Type | Description |
| 08/21/2023 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 7,142 shares
@ $10.7287, valued at
$76.6k
Exercised 1,773 restricted stock units
@ $0
Exercised 2,430 restricted stock units
@ $0
Exercised 7,291 rights
@ $0 |
|
| 05/22/2023 |
4/A
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Exercised 2,430 options to buy
@ $0 |
|
| 05/19/2023 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 2,604 shares
@ $10.1444, valued at
$26.4k
Granted 29,166 restricted stock units
@ $0
Exercised 2,431 restricted stock units
@ $0
Exercised 1,774 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 2,727 shares
@ $7.66, valued at
$20.9k
Exercised 2,430 options to buy
@ $0
Exercised 1,774 restricted stock units
@ $0 |
|
| 11/21/2022 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 1,139 shares
@ $5.44, valued at
$6.2k
Exercised 1,774 restricted stock units
@ $0 |
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $18.0656, valued at
$90.3k
|
|
| 08/04/2021 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $20.5157, valued at
$102.6k
|
|
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2020 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 80,000 options to buy
@ $10.2, valued at
$816k
|
|
| 11/02/2020 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $17.4788, valued at
$87.4k
|
|
| 10/22/2020 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 5,640 shares
@ $17.2729, valued at
$97.4k
Sold 2,302 shares
@ $18.0133, valued at
$41.5k
Sold 3,500 shares
@ $17.6837, valued at
$61.9k
Sold 2,544 shares
@ $19.0207, valued at
$48.4k
|
|
| 10/20/2020 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 914 shares
@ $17.0014, valued at
$15.5k
|
|
| 02/07/2020 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 100 shares
@ $17.1, valued at
$1.7k
|
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2019 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 199 shares
@ $17, valued at
$3.4k
Sold 1,500 shares
@ $17.0453, valued at
$25.6k
Sold 3,010 shares
@ $17.0493, valued at
$51.3k
Exercised 199 options to buy
@ $0.0043, valued at
$0.9
Exercised 1,500 options to buy
@ $0.0043, valued at
$6.5
Exercised 3,010 options to buy
@ $0.0043, valued at
$12.9 |
|
| 07/24/2019 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 7,355 shares
@ $18.3453, valued at
$134.9k
Exercised 7,355 options to buy
@ $0.0043, valued at
$31.6 |
|
| 05/17/2019 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 27,900 options to buy
@ $24.23, valued at
$676k
|
|
| 04/23/2019 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 6,355 shares
@ $25.9235, valued at
$164.7k
Sold 1,000 shares
@ $26.786, valued at
$26.8k
Exercised 7,355 options to buy
@ $0.0043, valued at
$31.6 |
|
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2019 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 1,302 shares
@ $17.0038, valued at
$22.1k
Sold 600 shares
@ $17.0083, valued at
$10.2k
Exercised 1,302 options to buy
@ $0.0043, valued at
$5.6
Exercised 600 options to buy
@ $0.0043, valued at
$2.6 |
|
| 01/24/2019 |
4/A
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 116,810 options to buy
@ $0 |
|
| 09/20/2018 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 52,600 options to buy
@ $16.08, valued at
$845.8k
|
|
| 06/06/2018 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 53,500 options to buy
@ $8.21, valued at
$439.2k
|
|
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/29/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |